NCT02692313View on ClinicalTrials.gov

Dose Response of Epinephrine

EARLY_PHASE1CompletedINTERVENTIONAL
Enrollment

32

Participants

Timeline

Start Date

June 30, 2016

Primary Completion Date

September 30, 2025

Study Completion Date

September 30, 2025

Conditions
Diabetes Complications
Interventions
DRUG

Epinephrine

Dose response of epinephrine infusion

OTHER

Saline infusion

Placebo

Trial Locations (1)

21201

University of Maryland, Baltimore, Baltimore

All Listed Sponsors
collaborator

Vanderbilt University

OTHER

lead

University of Maryland, Baltimore

OTHER

NCT02692313 - Dose Response of Epinephrine | Biotech Hunter | Biotech Hunter